Imunon, Inc. Line of Credit Facility, Maximum Borrowing Capacity
Imunon, Inc. (IMNN) had Line of Credit Facility, Maximum Borrowing Capacity of $10.00 million as of 2012-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2014-08-07
- 2012-06-30: Line of Credit Facility, Maximum Borrowing Capacity $10.00M.
- 2012-06-27: Line of Credit Facility, Maximum Borrowing Capacity $10.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2012-06-30 | $10.00M 10-Q · filed 2014-08-07 |
| 2012-06-27 | $10.00M 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |